Kemira Oyj Stock Exchange Release March 24, 2014 at 3.30 pm (CET+1) The Annual General Meeting of Kemira Oyj approved the Board of Directors proposal of EUR 0.53 dividend per share for the financial year 2013. The Annual General Meeting elected six members (previously five) to the Board of Directors. Annual General Meeting reelected Winnie Fok, Juha Laaksonen, Jari Paasikivi and Kerttu Tuomas and elected Wolfgang Büchele and Timo Lappalainen as new members. Jari Paasikivi was elected as the Board's Chairman and Kerttu Tuomas was elected as the Vice Chairman. Wolfgang Büchele (b. 1959), Dr. rer. nat. will leave his position as Kemira Oyj's President and CEO as of April 30, 2014 and start as Linde AG's President and CEO as of May 20, 2014. He is currently also a member of the Supervisory Board of Merck KGaA (to be proposed as the Chairman of the Supervisory Board). Timo Lappalainen (b. 1962), M. Sc. (Eng) is currently working as President and CEO of Orion Oyj. He is currently also a member of the Board of ICC Finland and the Vice Chairman of the Board of Chemical Industry Federation of Finland. Dividend payment The dividend of EUR 0.53 per share will be paid to a shareholder who is registered in the company's Shareholder Register maintained by Euroclear Finland Ltd. on the dividend record date for dividend payment, March 27, 2014. The dividend will be paid out on April 3, 2014. Remuneration of the Chairman, the Vice Chairman and the members of the Board of Directors The Annual General Meeting decided that the remuneration paid to the members of the Board of Directors will be as follows: the Chairman will receive EUR 74,000 per year, the Vice Chairman and the Chairman of the Audit Committee EUR 45,000 per year and the other members EUR 36,000 per year. A fee payable for each meeting of the Board of Directors and the Board Committees will be EUR 600 for the members residing in Finland, EUR 1,200 for the members residing in rest of Europe and EUR 2,400 for the members residing outside Europe. Travel expenses are paid according to Kemira's travel policy. In addition, the Annual General Meeting decided that the annual fee be paid as a combination of the company's shares and cash in such a manner that 40% of the annual fee is paid with the company's shares owned by the company or, if this is not possible, shares purchased from the market, and 60% is paid in cash. The shares will be transferred to the members of the Board of Directors and, if necessary, acquired directly on behalf of the members of the Board of Directors within two weeks from the release of Kemira's Interim Report January 1 - March 31, 2014. The meeting fees are to be paid in cash. Election of the auditor Deloitte & Touche Oy was elected as the company's auditor with Jukka Vattulainen, APA, acting as the principal author. The Auditor's fees will be paid against an invoice approved by Kemira. Authorization to decide on the repurchase of the company's own shares The Annual General Meeting authorized the Board of Directors to decide upon repurchase of a maximum of 4,500,000 company's own shares ("Share repurchase authorization"). Shares will be repurchased by using unrestricted equity either through a tender offer with equal terms to all shareholders at a price determined by the Board of Directors or otherwise than in proportion to the existing shareholdings of the company's shareholders in public trading on the NASDAQ OMX Helsinki Ltd (the "Helsinki Stock Exchange") at the market price quoted at the time of the repurchase. The price paid for the shares repurchased through a tender offer under the authorization shall be based on the market price of the company's shares in public trading. The minimum price to be paid would be the lowest market price of the share quoted in public trading during the authorization period and the maximum price the highest market price quoted during the authorization period. Shares shall be acquired and paid for in accordance with the Rules of the Helsinki Stock Exchange and Euroclear Finland Ltd. Shares may be repurchased to be used in implementing or financing mergers and acquisitions, developing the company's capital structure, improving the liquidity of the company's shares or to be used for the payment of the annual fee payable to the members of the Board of Directors or implementing the company's share-based incentive plans. In order to realize the aforementioned purposes, the shares acquired may be retained, transferred further or cancelled by the company. The Board of Directors will decide upon other terms related to share repurchase. The Share repurchase authorization is valid until the end of the next Annual General Meeting. Authorization to decide on share issue The Annual General Meeting authorized the Board of Directors to decide to issue a maximum of 15,600,000 new shares and/or transfer a maximum of 7,800,000 company's own shares held by the company ("Share issue authorization"). The new shares may be issued and the company's own shares held by the company may be transferred either for consideration or without consideration. The new shares may be issued and the company's own shares held by the company may be transferred to the company's shareholders in proportion to their current shareholdings in the company, or by disapplying the shareholders' pre-emption right, through a directed share issue, if the company has a weighty financial reason to do so, such as financing or implementing mergers and acquisitions, developing the capital structure of the company, improving the liquidity of the company's shares or if this is justified for the payment of the annual fee payable to the members of the Board of Directors or implementing the company's share-based incentive plans. The directed share issue may be carried out without consideration only in connection with the implementation of the company's share- based incentive plan. The subscription price of new shares shall be recorded to the invested unrestricted equity reserves. The consideration payable for company's own shares shall be recorded to the invested unrestricted equity reserves. The Board of Directors will decide upon other terms related to the share issues. The Share issue authorization is valid until May 31, 2015. For more information, please contact Kemira Oyj Tero Huovinen, VP, Investor Relations Tel. +358 10 862 1980 Kemira is a global chemicals company serving customers in water-intensive industries. We provide expertise and chemicals that improve our customers' water, energy and raw material efficiency. Our focus is on pulp & paper, oil & gas, mining and water treatment. In 2013, Kemira had annual revenue of EUR 2.2 billion and around 4,500 employees. Kemira shares are listed on the NASDAQ OMX Helsinki Ltd. www.kemira.com [HUG#1771067]
Kemira Oyj: Jari Paasikivi elected as new Chairman of the
Top 10 Most Recent News Articles
Algorized's AFM: A New Era for Human-Machine Interaction
Breaking Ground with Innovative Tech at CIIE 2026 When it comes to understanding human movement and biology, Algorized is rewriting the rules. Their Algorized Foundation Model (AFM) is strutting its stuff at the China International Import Expo 2026 (CIIE) in Shanghai, showcasing a whole new level of human-machine interaction that transcends mere technological wizardry....
Continue Reading
Island Pacific Opens 22nd Store in Eagle Rock, L.A.
Winning the Grocery Game One Store at a Time Here's the scoop—Island Pacific Seafood Market just rolled up the shutters on their 22nd supermarket at 4044 N. Eagle Rock Boulevard in the bustling hub of Glassell Park, Los Angeles. This ain't just some ho-hum store opening; it's a celebration rooted in Filipino heritage, smack in the middle of Northeast L.A., where culture...
Continue Reading
CPT Group Webinar Tackles AI Ethics in Class Actions
Diving into AI's Legal Labyrinth It's no secret that artificial intelligence is elbowing its way into every corner of our lives—from how we shop to how we drive, and now, it's nosing into the legal realm in a big way. CPT Group, a heavyweight in class action settlement administration, is stepping up to talk AI in the law game. They're rolling out a CLE webinar this...
Continue Reading
Omnicom Media: A Titan in Media Management Unveiled
Omnicom Media's Latest Triumph Omnicom Media (NYSE: OMC) just snagged the 'Leader' badge in the ruthless world of media management services, according to Forrester's new report. Picture a chess game where every move counts—Omnicom's been playing for years, and they're a grandmaster at this point. This isn't some pat on the back; it's recognition of a powerhouse...
Continue Reading
Nuvo's INVU™ Trial Reveals Boost in Fetal Monitoring
Remote Fetal Monitoring: A Game Changer in Prenatal Care? In the world of high-risk pregnancies, routine checkups aren't just a suggestion—they're vital. But when the logistics of shuttling back and forth to clinics get tangled with everyday life, something's gotta give. Enter Nuvo's INVU™. The REACTIVE trial, a Penn Medicine-led event funded by the NIH, aimed to see...
Continue Reading
NORROY's Radiopharma Innovations: EANM Highlights
Breaking Ground: NORROY's Radiopharmaceutical Innovations If you thought the radiopharmaceutical game was stuck in the same ol' rut, NORROY Bioscience just flipped the script. Standing out at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM'26) in Vienna, they trotted out enough breakthroughs to make you wonder if they're secretly running on...
Continue Reading
Qfin Holdings Faces Class Action Over Stock Drop
Qfin Holdings' Troubled Waters Look, when a stock tanks by nearly 19% overnight, it isn't because of some fluke. And that's precisely what's got Qfin Holdings, Inc. investors gritting their teeth and lawyers sharpening their pencils. Deep Dive into Allegations For those keeping score, we're talking about serious allegations here: between March 18, 2026, and August 25,...
Continue Reading
FuelCell Faces Lawsuit as Shares Tumble: Legal Insights
FuelCell's Latest Trials: Legal Hurdles and Investor Jitters Nothing like waking up to find your stock down 15.69%, smacking you right in the investment portfolio. That's the bitter pill FuelCell Energy, Inc. (NASDAQ: FCEL) investors had to swallow. FuelCell's recent nosedive wasn't just a market fluke—there's a class action lawsuit stirring up a storm. Background on...
Continue Reading
Houston IP Firm Reaches New Heights in 2027 Rankings
Heim, Payne & Chorush: A Legal Powerhouse When you think of top-tier intellectual property firms in the Lone Star State, Heim, Payne & Chorush, LLP isn't just on the list—they're setting the standard. Freshly minted as one of the top dogs in the 2027 Best Law Firms rankings, their accolade-heavy journey screams seasoned expertise. They've nailed down the kind of...
Continue Reading
RetailMeNot Boosts Holiday Budget with Cash Back Extravaganza
This Isn't Your Grandma's Cash Back Here we go, folks! RetailMeNot is rolling out the red carpet for budget-conscious gift givers with its National Cash Back Day. From November 5–7, over 3,500 retailers, including big shots like Walmart and Ulta, are letting you scoop up to 30% in cold, hard cash back. If you ever needed a reason to start your holiday shopping early,...
Continue ReadingTop 5 Most Recently Viewed Articles
Alex Nwaka Takes Charge as CEO to Pioneer the AI Wave
Alex Nwaka Appointed CEO, Driving Next-Gen AI Platforms In an exciting development, Validation Cloud revealed that co-founder Alex Nwaka has been appointed as the Chief Executive Officer. This pivotal move marks the beginning of a new era for the company as it strives to shape an AI platform tailored for the burgeoning digital asset economy, projected to reach a...
Continue Reading
Epiq Expands Class Action Leadership With Strategic Acquisition
Epiq's Strategic Acquisition of Case Pilots Epiq recently took a significant step in bolstering its leadership in class action administration by acquiring Case Pilots, a prominent claims administration company in the UK. This move not only enhances Epiq's capabilities but also reflects its commitment to providing innovative solutions in the legal sector. Enhancing Class...
Continue Reading
Insights from Cathie Wood on Bitcoin's Future Potential
Cathie Wood's Take on Cryptocurrency Cathie Wood and her team at Ark Invest are stirring up discussions with their insights on cryptocurrency. They believe this digital currency represents a major shift in how the world handles money. With its ease of access, global reach, and privacy features, cryptocurrency is emerging as a valuable option for wealth storage and...
Continue Reading
Legal Action Against Mariner Finance, LLC for Discrimination
Mariner Finance Faces Lawsuit Over Alleged Discrimination Mariner Finance, LLC is currently facing serious accusations from a former employee who claims that she was wrongfully terminated due to her medical condition and reproductive health decisions. The plaintiff was reportedly dismissed from her job after requesting additional time off for her leave of absence. This...
Continue Reading
Craneware plc Publishes a Key Trading Disclosure Notice
Introduction to Craneware plc's Trading Disclosure Craneware plc, a prominent player in the healthcare technology space, has officially announced a significant trading disclosure following the rules established in the Takeover Code. This notification serves as an important communication to stakeholders about recent trading activities that involve exempt principal traders...
Continue Reading